Allergan's Q4 revenues up

Allergan’s fourth-quarter revenues rose by 6.6 percent to $4,351million. The group posted an operating loss of $276.6 million for the period compared with an operating loss of $5,384 million a year earlier. On an adjusted basis, it booked an operating income of $2.079 million, up by 8.4 percent. Allergan expects ...

To continue reading this article register now.

Already an Eyewear Intelligence subscriber? Sign in here.


Become a member today for full access from just €7,29 a week!

Buying a membership today will give you:

  • Unlimited access to - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

Or sign-up for a trial month for just 9,90€. To continue reading this article register now.